Showing results (231-240 of 317) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|May 5, 2023
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasmsMark Gurney, Ismahene Chekkaf, Anmol Baranwal, et al.
American Journal of Hematology|September 27, 2024
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosisAyalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, et al.
Blood Cancer Journal|April 11, 2026
CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemiaSaubia Fathima, Lior Rokach, Muhammad Yousuf, et al.
Leukemia|December 15, 2019
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patientsGiacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, et al.
Leukemia & Lymphoma|August 27, 2021
Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosisRami Komrokji, Megan Melody, Najla Al Ali, et al.
Ebiomedicine|May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating AgentsMatthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Seminars in Arthritis and Rheumatism|July 25, 2025
Developing efficient predictive models for the diagnosis of VEXAS syndromeDaniel Montes, Andrew C Hanson, Hannah E Langenfeld, et al.
Blood Neoplasia|September 8, 2025
Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 studyMrinal M Patnaik, Haris Ali, Eunice S Wang, et al.
American Journal of Hematology|September 4, 2023
Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variantsAlejandro Ferrer, Terra Lasho, Jenna A Fernandez, et al.
Mayo Clinic Proceedings|March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease SubgroupsNatasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
Pageof 32